Addressing Hot Topics in Oncology With the ASCO CMO
Healthcare Unfiltered
00:00
The Impact of the Drug Shortage on the Market
In the United States we pay the highest amount for the on-patents cancer drugs all these every pay the lowest amount for the generics out there because this free fall where it goes generic and companies compete they underprice each other. The FDA doesn't have the legal authority to demand to know where a given manufacturer is getting the raw materials from if they can ask but they can be told for proprietary information well it turns out that we didn't have redundancy in the system for the platinum agents, he says.
Transcript
Play full episode
